カテゴリ： Allied Market Research, 世界, 医療/バイオ

血管塞栓のグローバル市場（2021〜2031）：塞栓剤、塞栓術装置

■ 英語タイトル：Vascular Embolization Market By Product (Embolic Agents, Embolization Devices), By Application (Oncology, Peripheral Vascular Diseases, Urology and Nephrology, Neurology, Others), By End User (Hospitals and Clinics, Ambulatory Surgical Centers, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031
	■ 発行会社/調査会社：Allied Market Research ■ 商品コード：ALD23FB215 ■ 発行日：2022年10月 ■ 調査対象地域：グローバル ■ 産業分野：医療 ■ ページ数：282 ■ レポート言語：英語 ■ レポート形式：PDF ■ 納品方式：Eメール（受注後24時間以内）

■ 販売価格オプション（消費税別）

Online Only（1名閲覧、印刷不可）	USD3,570 ⇒換算￥542,640	見積依頼/購入/質問フォーム
Single User（1名閲覧）	USD5,730 ⇒換算￥870,960	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数無制限）	USD9,600 ⇒換算￥1,459,200	見積依頼/購入/質問フォーム

※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Allied Market Research社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[血管塞栓のグローバル市場（2021〜2031）：塞栓剤、塞栓術装置]についてメールでお問い合わせはこちら

*** レポート概要（サマリー）***

Allied Market Research社の本市場調査レポートでは、2021年に3,682.73百万ドルであった世界の血管塞栓市場規模が、2031年までに7,780.98百万ドルに到達し、2022年から2031年にかけてCAGR（年平均成長率）7.7%で成長すると予測しています。本レポートは、血管塞栓の世界市場を総合的に調査・分析した資料であり、イントロダクション、エグゼクティブサマリー、市場概要、製品別（塞栓剤、塞栓術装置）分析、用途別（腫瘍学、末梢血管疾患、泌尿器科・腎臓科、神経内科、その他）分析、エンドユーザー別（病院・診療所、外来手術センター、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米・中東・アフリカ）分析、企業状況、企業情報などを掲載しています。また、本レポートは、BOSTON SCIENTIFIC CORPORATION、MERIT MEDICAL SYSTEMS、TERUMO CORPORATION、MEDTRONIC PLC、ABBOTT LABORATORIESなどの企業情報を含んでいます。
・イントロダクション
・エグゼクティブサマリー
・市場概要
・世界の血管塞栓市場規模：製品別
- 塞栓剤における市場規模
- 塞栓術装置における市場規模
・世界の血管塞栓市場規模：用途別
- 腫瘍学における市場規模
- 末梢血管疾患における市場規模
- 泌尿器科・腎臓科における市場規模
- 神経内科における市場規模
- その他における市場規模
・世界の血管塞栓市場規模：エンドユーザー別
- 病院・診療所における市場規模
- 外来手術センターにおける市場規模
- その他における市場規模
・世界の血管塞栓市場規模：地域別
- 北米の血管塞栓市場規模
- ヨーロッパの血管塞栓市場規模
- アジア太平洋の血管塞栓市場規模
- 中南米・中東・アフリカの血管塞栓市場規模
・企業状況
・企業情報

世界の血管塞栓市場は、2021年に36億8,273万ドルと評価され、2022年から2031年までの年平均成長率は7.7%を記録し、2031年には77億8,098万ドルに達すると予測されています。

塞栓術と呼ばれる低侵襲のプロセスは、特定の場所の血流を阻害します。この処置は、問題のある出血を管理しながら組織を保護するために、周辺部位の通常の血流を維持しながら行われます。血管が詰まることを塞栓症といい、医学的な理由で意図的に血管を塞ぐことを塞栓術といいます。コイル塞栓術と呼ばれるカテーテルを用いた手技により、動脈の異常な血流を正確に遮断することができます。通常は鼠径部にある動脈に、金属製の閉塞コイルを装着したカテーテルを挿入します（大腿動脈）。

そして、前進によって異常血管に到達します。血流とともに前進し、カテーテルやコイルでは到達できないような血管床の深部まで浸透することで、液体塞栓剤は標的血管を充満させ、血管閉塞を引き起こす能力があります。着脱式バルーンによる塞栓は、バルーンを取り外すまで可逆的であるなど、他の塞栓術よりも優れています。世界の血管塞栓市場の成長は、血管疾患の憂慮すべき有病率の増加が主な要因です。また、塞栓術の技術や製品による血管疾患治療の改善も、血管塞栓市場の成長を加速させています。

さらに、血管閉塞のための非侵襲的処置における塞栓プラグの成功率の増加、従来の処置の実行可能な代替手段としての利用可能性、およびこの他の技術の進歩は、市場をさらに推進すると予想されます。一例を挙げると、St. Jude Medical社のアンプラッツァー・プラグ4は市場で容易に入手可能です。しかし、血管塞栓のコストが高いこと、それに伴う合併症が市場の成長を妨げています。加えて、化学療法や放射線療法といった治療法は、がんの治療において好ましい選択肢です。また、塞栓剤を誤った場所に留置してしまうと、正常な組織から酸素を奪ってしまう危険性があります。これらは市場の成長にマイナスの影響を与える要因です。

世界の血管塞栓市場は、製品、用途、エンドユーザーに区分されます。製品別では、塞栓剤と塞栓デバイスに分類されます。塞栓剤と塞栓デバイスは、さらに液体塞栓剤とマイクロスフェアに細分化されます。また、塞栓デバイスはコイル、着脱式バルーン、塞栓プラグ、サポートデバイスに分類されます。用途別では、腫瘍、末梢血管疾患、泌尿器・腎臓、神経、その他に分類されます。エンドユーザー別では、病院・診療所、外来手術センター、その他に分けられます。地域別では、北米（米国、カナダ、メキシコ）、欧州（ドイツ、フランス、英国、イタリア、スペイン、および欧州のその他地域）、アジア太平洋（日本、中国、オーストラリア、インド、韓国、およびアジア太平洋のその他地域）、およびLAMEA（ブラジル、南アフリカ、サウジアラビア、およびLAMEAのその他地域）に市場を分けて分析しています。

世界の血管塞栓市場における主な主要企業は、 Abbott Laboratories、Balt Group、Boston Scientific Corporation、Cook Medical、Johnson and Johnson、株式会社カネカ、Medtronic Plc、Merit Medical、Stryker Corporation、Terumo Medical Corporationなどです。

〈ステークホルダーにとっての主なメリット〉
・血管塞栓の市場機会を特定するため、2021年から2031年までの市場セグメント、現在の動向、予測、市場ダイナミクスを定量的に分析します。
・主要な促進要因、阻害要因、機会に関する情報とともに市場調査を提供します。
・ポーターのファイブフォース分析により、バイヤーとサプライヤーの潜在力を明らかにし、ステークホルダーが利益重視のビジネス決定を下し、サプライヤーとバイヤーのネットワークを強化できるようにします。
・血管塞栓市場のセグメンテーションを詳細に分析することで、市場機会を見極めることができます。
・各地域の主要国を世界市場への収益貢献度に応じてマッピングしています。
・市場プレイヤーのポジショニングはベンチマーキングを容易にし、市場プレイヤーの現在のポジションを明確に理解することができます。
・血管塞栓の地域別および世界市場動向、主要企業、市場セグメント、応用分野、市場成長戦略の分析を含みます。

〈主要市場セグメント〉
製品別
塞栓剤
塞栓デバイス

用途別
腫瘍
末梢血管疾患
泌尿器科・腎臓内科
神経内科
その他

エンドユーザー別
病院・クリニック
外来手術センター
その他

地域別
・北米
米国
カナダ
メキシコ
・ヨーロッパ
ドイツ
フランス
イギリス
イタリア
スペイン
その他のヨーロッパ
・アジア太平洋
中国
日本
インド
オーストラリア
韓国
その他のアジア太平洋地域
・LAMEA
ブラジル
サウジアラビア
南アフリカ
その他のLAMEA地域

〈主要市場プレイヤー〉
BOSTON SCIENTIFIC CORPORATION
MERIT MEDICAL SYSTEMS
TERUMO CORPORATION
MEDTRONIC PLC
ABBOTT LABORATORIES
DEPUY SYNTHES (J&J MEDICAL DEVICES)
COOK MEDICAL
BALT
株式会社カネカ
STRYKER CORPORATION

*** レポート目次（コンテンツ）***

CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: VASCULAR EMBOLIZATION MARKET, BY PRODUCT
4.1 Overview
4.1.1 Market size and forecast
4.2 Embolic Agents
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.2.4 Embolic Agents Vascular Embolization Market by Type
4.2.4.1 Liquid Embolic Agents Market size and forecast, by region
4.2.4.2 Microspheres Market size and forecast, by region
4.3 Embolization Devices
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.3.4 Embolization Devices Vascular Embolization Market by Type
4.3.4.1 Coils Market size and forecast, by region
4.3.4.2 Detachable Balloons Market size and forecast, by region
4.3.4.3 Embolic Plug Market size and forecast, by region
4.3.4.4 Support Devices Market size and forecast, by region
CHAPTER 5: VASCULAR EMBOLIZATION MARKET, BY APPLICATION
5.1 Overview
5.1.1 Market size and forecast
5.2 Oncology
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Peripheral Vascular Diseases
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.4 Urology and Nephrology
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country
5.5 Neurology
5.5.1 Key market trends, growth factors and opportunities
5.5.2 Market size and forecast, by region
5.5.3 Market analysis by country
5.6 Others
5.6.1 Key market trends, growth factors and opportunities
5.6.2 Market size and forecast, by region
5.6.3 Market analysis by country
CHAPTER 6: VASCULAR EMBOLIZATION MARKET, BY END USER
6.1 Overview
6.1.1 Market size and forecast
6.2 Hospitals and Clinics
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.3 Ambulatory Surgical Centers
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
6.4 Others
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market analysis by country
CHAPTER 7: VASCULAR EMBOLIZATION MARKET, BY REGION
7.1 Overview
7.1.1 Market size and forecast
7.2 North America
7.2.1 Key trends and opportunities
7.2.2 North America Market size and forecast, by Product
7.2.2.1 North America Embolic Agents Vascular Embolization Market by Type
7.2.2.2 North America Embolization Devices Vascular Embolization Market by Type
7.2.3 North America Market size and forecast, by Application
7.2.4 North America Market size and forecast, by End User
7.2.5 North America Market size and forecast, by country
7.2.5.1 U.S.
7.2.5.1.1 Market size and forecast, by Product
7.2.5.1.2 Market size and forecast, by Application
7.2.5.1.3 Market size and forecast, by End User
7.2.5.2 Canada
7.2.5.2.1 Market size and forecast, by Product
7.2.5.2.2 Market size and forecast, by Application
7.2.5.2.3 Market size and forecast, by End User
7.2.5.3 Mexico
7.2.5.3.1 Market size and forecast, by Product
7.2.5.3.2 Market size and forecast, by Application
7.2.5.3.3 Market size and forecast, by End User
7.3 Europe
7.3.1 Key trends and opportunities
7.3.2 Europe Market size and forecast, by Product
7.3.2.1 Europe Embolic Agents Vascular Embolization Market by Type
7.3.2.2 Europe Embolization Devices Vascular Embolization Market by Type
7.3.3 Europe Market size and forecast, by Application
7.3.4 Europe Market size and forecast, by End User
7.3.5 Europe Market size and forecast, by country
7.3.5.1 Germany
7.3.5.1.1 Market size and forecast, by Product
7.3.5.1.2 Market size and forecast, by Application
7.3.5.1.3 Market size and forecast, by End User
7.3.5.2 France
7.3.5.2.1 Market size and forecast, by Product
7.3.5.2.2 Market size and forecast, by Application
7.3.5.2.3 Market size and forecast, by End User
7.3.5.3 UK
7.3.5.3.1 Market size and forecast, by Product
7.3.5.3.2 Market size and forecast, by Application
7.3.5.3.3 Market size and forecast, by End User
7.3.5.4 Italy
7.3.5.4.1 Market size and forecast, by Product
7.3.5.4.2 Market size and forecast, by Application
7.3.5.4.3 Market size and forecast, by End User
7.3.5.5 Spain
7.3.5.5.1 Market size and forecast, by Product
7.3.5.5.2 Market size and forecast, by Application
7.3.5.5.3 Market size and forecast, by End User
7.3.5.6 Rest of Europe
7.3.5.6.1 Market size and forecast, by Product
7.3.5.6.2 Market size and forecast, by Application
7.3.5.6.3 Market size and forecast, by End User
7.4 Asia-Pacific
7.4.1 Key trends and opportunities
7.4.2 Asia-Pacific Market size and forecast, by Product
7.4.2.1 Asia-Pacific Embolic Agents Vascular Embolization Market by Type
7.4.2.2 Asia-Pacific Embolization Devices Vascular Embolization Market by Type
7.4.3 Asia-Pacific Market size and forecast, by Application
7.4.4 Asia-Pacific Market size and forecast, by End User
7.4.5 Asia-Pacific Market size and forecast, by country
7.4.5.1 China
7.4.5.1.1 Market size and forecast, by Product
7.4.5.1.2 Market size and forecast, by Application
7.4.5.1.3 Market size and forecast, by End User
7.4.5.2 Japan
7.4.5.2.1 Market size and forecast, by Product
7.4.5.2.2 Market size and forecast, by Application
7.4.5.2.3 Market size and forecast, by End User
7.4.5.3 India
7.4.5.3.1 Market size and forecast, by Product
7.4.5.3.2 Market size and forecast, by Application
7.4.5.3.3 Market size and forecast, by End User
7.4.5.4 Australia
7.4.5.4.1 Market size and forecast, by Product
7.4.5.4.2 Market size and forecast, by Application
7.4.5.4.3 Market size and forecast, by End User
7.4.5.5 South Korea
7.4.5.5.1 Market size and forecast, by Product
7.4.5.5.2 Market size and forecast, by Application
7.4.5.5.3 Market size and forecast, by End User
7.4.5.6 Rest of Asia-Pacific
7.4.5.6.1 Market size and forecast, by Product
7.4.5.6.2 Market size and forecast, by Application
7.4.5.6.3 Market size and forecast, by End User
7.5 LAMEA
7.5.1 Key trends and opportunities
7.5.2 LAMEA Market size and forecast, by Product
7.5.2.1 LAMEA Embolic Agents Vascular Embolization Market by Type
7.5.2.2 LAMEA Embolization Devices Vascular Embolization Market by Type
7.5.3 LAMEA Market size and forecast, by Application
7.5.4 LAMEA Market size and forecast, by End User
7.5.5 LAMEA Market size and forecast, by country
7.5.5.1 Brazil
7.5.5.1.1 Market size and forecast, by Product
7.5.5.1.2 Market size and forecast, by Application
7.5.5.1.3 Market size and forecast, by End User
7.5.5.2 Saudi Arabia
7.5.5.2.1 Market size and forecast, by Product
7.5.5.2.2 Market size and forecast, by Application
7.5.5.2.3 Market size and forecast, by End User
7.5.5.3 South Africa
7.5.5.3.1 Market size and forecast, by Product
7.5.5.3.2 Market size and forecast, by Application
7.5.5.3.3 Market size and forecast, by End User
7.5.5.4 Rest of LAMEA
7.5.5.4.1 Market size and forecast, by Product
7.5.5.4.2 Market size and forecast, by Application
7.5.5.4.3 Market size and forecast, by End User
CHAPTER 8: COMPANY LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments
CHAPTER 9: COMPANY PROFILES
9.1 BOSTON SCIENTIFIC CORPORATION
9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Operating business segments
9.1.4 Product portfolio
9.1.5 Business performance
9.1.6 Key strategic moves and developments
9.2 MERIT MEDICAL SYSTEMS
9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Operating business segments
9.2.4 Product portfolio
9.2.5 Business performance
9.2.6 Key strategic moves and developments
9.3 TERUMO CORPORATION
9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Operating business segments
9.3.4 Product portfolio
9.3.5 Business performance
9.3.6 Key strategic moves and developments
9.4 MEDTRONIC PLC
9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Operating business segments
9.4.4 Product portfolio
9.4.5 Business performance
9.4.6 Key strategic moves and developments
9.5 ABBOTT LABORATORIES
9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Operating business segments
9.5.4 Product portfolio
9.5.5 Business performance
9.5.6 Key strategic moves and developments
9.6 DEPUY SYNTHES (J&J MEDICAL DEVICES)
9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Operating business segments
9.6.4 Product portfolio
9.6.5 Business performance
9.6.6 Key strategic moves and developments
9.7 COOK MEDICAL
9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Operating business segments
9.7.4 Product portfolio
9.7.5 Business performance
9.7.6 Key strategic moves and developments
9.8 BALT
9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Operating business segments
9.8.4 Product portfolio
9.8.5 Business performance
9.8.6 Key strategic moves and developments
9.9 KANEKA CORPORATION
9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Operating business segments
9.9.4 Product portfolio
9.9.5 Business performance
9.9.6 Key strategic moves and developments
9.10 STRYKER CORPORATION
9.10.1 Company overview
9.10.2 Company snapshot
9.10.3 Operating business segments
9.10.4 Product portfolio
9.10.5 Business performance
9.10.6 Key strategic moves and developments

LIST OF TABLES
TABLE 1. GLOBAL VASCULAR EMBOLIZATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 2. VASCULAR EMBOLIZATION MARKET, FOR EMBOLIC AGENTS, BY REGION, 2021-2031 ($MILLION)
TABLE 3. VASCULAR EMBOLIZATION MARKET FOR EMBOLIC AGENTS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 4. GLOBAL EMBOLIC AGENTS VASCULAR EMBOLIZATION MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 5. VASCULAR EMBOLIZATION MARKET, FOR LIQUID EMBOLIC AGENTS, BY REGION, 2021-2031 ($MILLION)
TABLE 6. VASCULAR EMBOLIZATION MARKET, FOR MICROSPHERES, BY REGION, 2021-2031 ($MILLION)
TABLE 7. VASCULAR EMBOLIZATION MARKET, FOR EMBOLIZATION DEVICES, BY REGION, 2021-2031 ($MILLION)
TABLE 8. VASCULAR EMBOLIZATION MARKET FOR EMBOLIZATION DEVICES, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 9. GLOBAL EMBOLIZATION DEVICES VASCULAR EMBOLIZATION MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 10. VASCULAR EMBOLIZATION MARKET, FOR COILS, BY REGION, 2021-2031 ($MILLION)
TABLE 11. VASCULAR EMBOLIZATION MARKET, FOR DETACHABLE BALLOONS, BY REGION, 2021-2031 ($MILLION)
TABLE 12. VASCULAR EMBOLIZATION MARKET, FOR EMBOLIC PLUG, BY REGION, 2021-2031 ($MILLION)
TABLE 13. VASCULAR EMBOLIZATION MARKET, FOR SUPPORT DEVICES, BY REGION, 2021-2031 ($MILLION)
TABLE 14. GLOBAL VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 15. VASCULAR EMBOLIZATION MARKET, FOR ONCOLOGY, BY REGION, 2021-2031 ($MILLION)
TABLE 16. VASCULAR EMBOLIZATION MARKET FOR ONCOLOGY, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 17. VASCULAR EMBOLIZATION MARKET, FOR PERIPHERAL VASCULAR DISEASES, BY REGION, 2021-2031 ($MILLION)
TABLE 18. VASCULAR EMBOLIZATION MARKET FOR PERIPHERAL VASCULAR DISEASES, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 19. VASCULAR EMBOLIZATION MARKET, FOR UROLOGY AND NEPHROLOGY, BY REGION, 2021-2031 ($MILLION)
TABLE 20. VASCULAR EMBOLIZATION MARKET FOR UROLOGY AND NEPHROLOGY, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 21. VASCULAR EMBOLIZATION MARKET, FOR NEUROLOGY, BY REGION, 2021-2031 ($MILLION)
TABLE 22. VASCULAR EMBOLIZATION MARKET FOR NEUROLOGY, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 23. VASCULAR EMBOLIZATION MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 24. VASCULAR EMBOLIZATION MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 25. GLOBAL VASCULAR EMBOLIZATION MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 26. VASCULAR EMBOLIZATION MARKET, FOR HOSPITALS AND CLINICS, BY REGION, 2021-2031 ($MILLION)
TABLE 27. VASCULAR EMBOLIZATION MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 28. VASCULAR EMBOLIZATION MARKET, FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2021-2031 ($MILLION)
TABLE 29. VASCULAR EMBOLIZATION MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 30. VASCULAR EMBOLIZATION MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 31. VASCULAR EMBOLIZATION MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 32. VASCULAR EMBOLIZATION MARKET, BY REGION, 2021-2031 ($MILLION)
TABLE 33. NORTH AMERICA VASCULAR EMBOLIZATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 34. NORTH AMERICA EMBOLIC AGENTS VASCULAR EMBOLIZATION MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 35. NORTH AMERICA EMBOLIZATION DEVICES VASCULAR EMBOLIZATION MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 36. NORTH AMERICA VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 37. NORTH AMERICA VASCULAR EMBOLIZATION MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 38. NORTH AMERICA VASCULAR EMBOLIZATION MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 39. U.S. VASCULAR EMBOLIZATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 40. U.S. VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 41. U.S. VASCULAR EMBOLIZATION MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 42. CANADA VASCULAR EMBOLIZATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 43. CANADA VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 44. CANADA VASCULAR EMBOLIZATION MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 45. MEXICO VASCULAR EMBOLIZATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 46. MEXICO VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 47. MEXICO VASCULAR EMBOLIZATION MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 48. EUROPE VASCULAR EMBOLIZATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 49. EUROPE EMBOLIC AGENTS VASCULAR EMBOLIZATION MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 50. EUROPE EMBOLIZATION DEVICES VASCULAR EMBOLIZATION MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 51. EUROPE VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 52. EUROPE VASCULAR EMBOLIZATION MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 53. EUROPE VASCULAR EMBOLIZATION MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 54. GERMANY VASCULAR EMBOLIZATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 55. GERMANY VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 56. GERMANY VASCULAR EMBOLIZATION MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 57. FRANCE VASCULAR EMBOLIZATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 58. FRANCE VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 59. FRANCE VASCULAR EMBOLIZATION MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 60. UK VASCULAR EMBOLIZATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 61. UK VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 62. UK VASCULAR EMBOLIZATION MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 63. ITALY VASCULAR EMBOLIZATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 64. ITALY VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 65. ITALY VASCULAR EMBOLIZATION MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 66. SPAIN VASCULAR EMBOLIZATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 67. SPAIN VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 68. SPAIN VASCULAR EMBOLIZATION MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 69. REST OF EUROPE VASCULAR EMBOLIZATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 70. REST OF EUROPE VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 71. REST OF EUROPE VASCULAR EMBOLIZATION MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 72. ASIA-PACIFIC VASCULAR EMBOLIZATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 73. ASIA-PACIFIC EMBOLIC AGENTS VASCULAR EMBOLIZATION MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 74. ASIA-PACIFIC EMBOLIZATION DEVICES VASCULAR EMBOLIZATION MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 75. ASIA-PACIFIC VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 76. ASIA-PACIFIC VASCULAR EMBOLIZATION MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 77. ASIA-PACIFIC VASCULAR EMBOLIZATION MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 78. CHINA VASCULAR EMBOLIZATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 79. CHINA VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 80. CHINA VASCULAR EMBOLIZATION MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 81. JAPAN VASCULAR EMBOLIZATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 82. JAPAN VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 83. JAPAN VASCULAR EMBOLIZATION MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 84. INDIA VASCULAR EMBOLIZATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 85. INDIA VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 86. INDIA VASCULAR EMBOLIZATION MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 87. AUSTRALIA VASCULAR EMBOLIZATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 88. AUSTRALIA VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 89. AUSTRALIA VASCULAR EMBOLIZATION MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 90. SOUTH KOREA VASCULAR EMBOLIZATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 91. SOUTH KOREA VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 92. SOUTH KOREA VASCULAR EMBOLIZATION MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 93. REST OF ASIA-PACIFIC VASCULAR EMBOLIZATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 94. REST OF ASIA-PACIFIC VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 95. REST OF ASIA-PACIFIC VASCULAR EMBOLIZATION MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 96. LAMEA VASCULAR EMBOLIZATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 97. LAMEA EMBOLIC AGENTS VASCULAR EMBOLIZATION MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 98. LAMEA EMBOLIZATION DEVICES VASCULAR EMBOLIZATION MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 99. LAMEA VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 100. LAMEA VASCULAR EMBOLIZATION MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 101. LAMEA VASCULAR EMBOLIZATION MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 102. BRAZIL VASCULAR EMBOLIZATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 103. BRAZIL VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 104. BRAZIL VASCULAR EMBOLIZATION MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 105. SAUDI ARABIA VASCULAR EMBOLIZATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 106. SAUDI ARABIA VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 107. SAUDI ARABIA VASCULAR EMBOLIZATION MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 108. SOUTH AFRICA VASCULAR EMBOLIZATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 109. SOUTH AFRICA VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 110. SOUTH AFRICA VASCULAR EMBOLIZATION MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 111. REST OF LAMEA VASCULAR EMBOLIZATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 112. REST OF LAMEA VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 113. REST OF LAMEA VASCULAR EMBOLIZATION MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 114.BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
TABLE 115.BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS
TABLE 116.BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
TABLE 117.BOSTON SCIENTIFIC CORPORATION: NET SALES,
TABLE 118.BOSTON SCIENTIFIC CORPORATION: KEY STRATERGIES
TABLE 119.MERIT MEDICAL SYSTEMS: COMPANY SNAPSHOT
TABLE 120.MERIT MEDICAL SYSTEMS: OPERATING SEGMENTS
TABLE 121.MERIT MEDICAL SYSTEMS: PRODUCT PORTFOLIO
TABLE 122.MERIT MEDICAL SYSTEMS: NET SALES,
TABLE 123.MERIT MEDICAL SYSTEMS: KEY STRATERGIES
TABLE 124.TERUMO CORPORATION: COMPANY SNAPSHOT
TABLE 125.TERUMO CORPORATION: OPERATING SEGMENTS
TABLE 126.TERUMO CORPORATION: PRODUCT PORTFOLIO
TABLE 127.TERUMO CORPORATION: NET SALES,
TABLE 128.TERUMO CORPORATION: KEY STRATERGIES
TABLE 129.MEDTRONIC PLC: COMPANY SNAPSHOT
TABLE 130.MEDTRONIC PLC: OPERATING SEGMENTS
TABLE 131.MEDTRONIC PLC: PRODUCT PORTFOLIO
TABLE 132.MEDTRONIC PLC: NET SALES,
TABLE 133.MEDTRONIC PLC: KEY STRATERGIES
TABLE 134.ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 135.ABBOTT LABORATORIES: OPERATING SEGMENTS
TABLE 136.ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 137.ABBOTT LABORATORIES: NET SALES,
TABLE 138.ABBOTT LABORATORIES: KEY STRATERGIES
TABLE 139.DEPUY SYNTHES (J&J MEDICAL DEVICES): COMPANY SNAPSHOT
TABLE 140.DEPUY SYNTHES (J&J MEDICAL DEVICES): OPERATING SEGMENTS
TABLE 141.DEPUY SYNTHES (J&J MEDICAL DEVICES): PRODUCT PORTFOLIO
TABLE 142.DEPUY SYNTHES (J&J MEDICAL DEVICES): NET SALES,
TABLE 143.DEPUY SYNTHES (J&J MEDICAL DEVICES): KEY STRATERGIES
TABLE 144.COOK MEDICAL: COMPANY SNAPSHOT
TABLE 145.COOK MEDICAL: OPERATING SEGMENTS
TABLE 146.COOK MEDICAL: PRODUCT PORTFOLIO
TABLE 147.COOK MEDICAL: NET SALES,
TABLE 148.COOK MEDICAL: KEY STRATERGIES
TABLE 149.BALT: COMPANY SNAPSHOT
TABLE 150.BALT: OPERATING SEGMENTS
TABLE 151.BALT: PRODUCT PORTFOLIO
TABLE 152.BALT: NET SALES,
TABLE 153.BALT: KEY STRATERGIES
TABLE 154.KANEKA CORPORATION: COMPANY SNAPSHOT
TABLE 155.KANEKA CORPORATION: OPERATING SEGMENTS
TABLE 156.KANEKA CORPORATION: PRODUCT PORTFOLIO
TABLE 157.KANEKA CORPORATION: NET SALES,
TABLE 158.KANEKA CORPORATION: KEY STRATERGIES
TABLE 159.STRYKER CORPORATION: COMPANY SNAPSHOT
TABLE 160.STRYKER CORPORATION: OPERATING SEGMENTS
TABLE 161.STRYKER CORPORATION: PRODUCT PORTFOLIO
TABLE 162.STRYKER CORPORATION: NET SALES,
TABLE 163.STRYKER CORPORATION: KEY STRATERGIES

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/

H&I Global Research

血管塞栓のグローバル市場（2021〜2031）：塞栓剤、塞栓術装置

グローバル市場調査会社